Because the ultimate agreement was for a month suspension, she will serve the remaining eight days now, while there’s no competition, and be cleared to return to play as of Dec. 4.
Swiatek also was fined the prize money of $158,944 that she earned for her semifinal run at the Cincinnati Open in August, the event immediately following the positive test.
“Once the source of the TMZ had been established, it became clear that this was a highly unusual instance of a contaminated product, which in Poland is a regulated medicine. However, the product does not have the same designation globally, and the fact that a product is a regulated medication in one country cannot of itself be sufficient to avoid any level of fault,” ITIA CEO Karen Moorhouse said.
“Taking into account the nature of the medication, and all the circumstances, it does place that fault at the lowest end of the scale,” Moorhouse said. “This case is an important reminder for tennis players of the strict liability nature of the World Anti-Doping Code and the importance of players carefully considering the use of supplements and medications.”
